Epistaxis. Epistaxis
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group receive a hemostatic product containing tannic acid and tranexamic acid. These two drug compounds, which have coagulant properties, are used
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients with acute, new, or recurrent anterior epistaxis are enrolled in the study. Patients with bleeding who still require further treatment after 10 minutes of compression of both nostrils with the thumb and index finger. Absence of background diseases
Exclusion criteria
Exclusion criteria: People with traumatic epistaxis Current use of anticoagulant medications Inherited bleeding disorders (including hemophilia) or inherited platelet disorders Visible bleeding vein
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to stop nosebleed. Timepoint: From beginning of intervention until bleeding stops. Method of measurement: Time with a stopwatch. | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence of epistaxis within 24 hours after intervention. Timepoint: 24 hours after intervention. Method of measurement: Question via phone call (answer: yes/no).;Time of stay in hospital emergency. Timepoint: After intervention. Method of measurement: Watch.;Satisfaction with the intervention. Timepoint: Numeric rating scale (NRS). Method of measurement: Expressing numbers between 0 and 10.;Pain at insertion and removal. Timepoint: At intervention and after completing intervention. Method of measurement: visual analog scale (VAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactCyrus Jalili
Kermanshah University of Medical Sciences
Outcome results
None listed